Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2021-11-10

FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)

View source ↗

Summary

The FDA approved a supplemental application for VERSACLOZ (clozapine) submitted by TruPharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VERSACLOZ (CLOZAPINE)

Snippet

SUPPL AP for VERSACLOZ (CLOZAPINE)